Chapter 49. Presenilins and Notch Signaling Pathway
- Khalid Iqbal3,
- Sangram S. Sisodia4,
- Bengt Winblad5
Published Online: 18 APR 2002
DOI: 10.1002/0470846453.ch49
Copyright © 2001 John Wiley & Sons, Ltd
Book Title

Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics
Additional Information
How to Cite
Song, W. and Yankner, B. A. (2002) Presenilins and Notch Signaling Pathway, in Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics (eds K. Iqbal, S. S. Sisodia and B. Winblad), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470846453.ch49
Editor Information
- 3
Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, New York, NY 10314-6399, USA
- 4
Department of Neurobiology, Pharmacology and Physiology, University of Chicago, Abbot 316, 947 East 58th Street, Chicago, IL 60637, USA
- 5
Karolinska Institute, NEUROTEC, Huddinge University Hospital, B 84, S-141 86 Huddinge, Stockholm, Sweden
Publication History
- Published Online: 18 APR 2002
- Published Print: 28 MAR 2001
ISBN Information
Print ISBN: 9780471521761
Online ISBN: 9780470846452
- Summary
- Chapter
Keywords:
- Alzheimer's disease;
- dementia;
- presenilins;
- notch signalling;
- amyloid-β
Summary
Notch-1 is a member of a conserved family of transmembrane receptors that regulate cell fate decisions during development. A role for presenilins in the regulation of Notch signalling has been suggested by studies of the Caenorhabditis elegans presenilin homolog sel-12. These findings suggest that PS1 may regulate the Notch signaling pathway during development, although the cellular mechanism is unknown. We explore the possibility that PS1 and PS2 may also regulate proteolytic cleavage of Notch-1 intracellular domain. We now report that presenilins are absolutely required for the proteolytic release and nuclear translocation of the Notch-1 intracellular domain.
